Recently, Chinese innovative synbio startup SIYOMICRO completed nearly 200 million yuan of round B financing. This financing will be mainly used for the upgrading of synthetic biology automation engineering platform (SIYO-AI) and anti-fragile biology platform (SIYO-AF), accelerate the construction and operation of phase I of Shenzhen synthetic biology intelligent manufacturing base project, and further expand the synthetic biology R&D doctoral team and industrial operation expert team.

As a global professional innovative intelligent manufacturing enterprise of synthetic biology, SIYOMICRO has always been committed to providing new production methods and solutions for various industries around the world.

The company has built a core R&D team of high-level talents from the Chinese Academy of Sciences, Peking University, Tsinghua University, UC Berkeley, Wageningen UR, and other top universities and scientific research institutes at home and abroad, covering synthetic biology, chemistry, life science, ecology, environmental science, food science, and agricultural science. The interdisciplinary R&D team is the source power of SIYOMICRO's "one core" - synthetic biology enabling platform to improve the efficiency of engineering from modularization, quantification, and standardization.

In 2022, the company will also strengthen cooperation with first-class universities and scientific research institutions at home and abroad, expand R&D and industrial operation teams, accelerate the upgrading and transformation of automation engineering platform (SIYO-AI) and anti-fragile biological platform (SIYO-AF), build an ecological closed loop of industry-university research innovation, further shorten the cycle of "transfer from research to production" of new products, and accelerate the industrialization of many new projects such as agriculture, environmental protection, materials, and medical treatment.